As a first step in examining calpains’ potential role in peripheral demyelinating diseases, we here characterize the calpains and calpastatin during postnatal development, in a chronic model when normal myelination is disrupted, and in an acute demyelinating model. This evidence concerns the gene CAST and demyelinating disease.